[HTML][HTML] Major coagulation disorders and parameters in COVID-19 patients

A Teimury, MT Khameneh, EM Khaledi - European journal of medical …, 2022 - Springer
Abstract Coronavirus disease 2019 (COVID-19), with a high prevalence rate, has rapidly
infected millions of people around the world. Since viral infections can disrupt the …

[HTML][HTML] Increased susceptibility for thromboembolic events versus high bleeding risk associated with COVID-19

C Tudoran, DE Velimirovici, DM Berceanu-Vaduva… - Microorganisms, 2022 - mdpi.com
The infection with the SARS-CoV-2 virus is associated with numerous systemic
involvements. Besides the severe respiratory injuries and cardiovascular complications, it …

American Society of Hematology living guidelines on the use of anticoagulation for thromboprophylaxis in patients with COVID-19: May 2021 update on the use of …

A Cuker, EK Tseng, R Nieuwlaat… - Blood …, 2021 - ashpublications.org
Abstract Background: COVID-19–related critical illness is associated with an increased risk
of venous thromboembolism (VTE). Objective: These evidence-based guidelines of the …

Differential proinflammatory activities of Spike proteins of SARS-CoV-2 variants of concern

SD Tyrkalska, A Martínez-López, AB Arroyo… - Science …, 2022 - science.org
The coronavirus disease 2019 (COVID-19) pandemic turned the whole world upside down
in a short time. One of the main challenges faced has been to understand COVID-19 …

[HTML][HTML] Spontaneous muscle hematoma in patients with COVID-19: A systematic literature review with description of an additional case series

V Abate, A Casoria, D Rendina… - … in Thrombosis and …, 2022 - thieme-connect.com
Coagulation abnormalities, thrombosis, and endothelial dysfunction have been described in
COVID-19 patients. Spontaneous muscle hematoma (SMH) is a rare complication in COVID …

[HTML][HTML] Preventing thrombohemorrhagic complications of heparinized COVID-19 patients using adjunctive thromboelastography: a retrospective study

CM Bunch, AV Thomas, JE Stillson, L Gillespie… - Journal of Clinical …, 2021 - mdpi.com
Background: The treatment of COVID-19 patients with heparin is not always effective in
preventing thrombotic complications, but can also be associated with bleeding …

[HTML][HTML] Incidence, risk factors, and clinical impact of major bleeding in hospitalized patients with COVID-19: a sub-analysis of the CLOT-COVID Study

J Nakamura, I Tsujino, S Yachi, M Takeyama… - Thrombosis journal, 2022 - Springer
Background The coronavirus disease 2019 (COVID-19) causes extensive coagulopathy and
a potential benefit of anticoagulation therapy has been documented for prevention of …

[HTML][HTML] Major bleeding complications in COVID-19 patients

I Boira, V Esteban, S Vañes, C Castelló, C Celis… - Cureus, 2021 - ncbi.nlm.nih.gov
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection has been
associated with thrombotic phenomena in the early stages of the disease, but also, less …

Prevention of venous thromboembolism and haemostasis monitoring in patients with COVID-19: Updated proposals (April 2021): From the French working group on …

A Godon, CA Tacquard, A Mansour, D Garrigue… - … Critical Care & Pain …, 2021 - Elsevier
In April 2020, in response to the high thrombotic risk associated with COVID-19, the GIHP
and GFHT published proposals for the prevention of venous thromboembolism (VTE) and …

[HTML][HTML] Predictive ability of viscoelastic testing using ClotPro® for short-term outcome in patients with severe Covid-19 ARDS with or without ECMO therapy: a …

L Heubner, M Greiner, O Vicent, J Beyer-Westendorf… - Thrombosis …, 2022 - Springer
Background SARS-CoV-2 infections are suspected to trigger the coagulation system through
various pathways leading to a high incidence of thromboembolic complications …